PI3K/Akt/mTOR and CDK4 combined inhibition enhanced apoptosis of thyroid cancer cell lines

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 443

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJABBR-8-2_010

تاریخ نمایه سازی: 23 تیر 1399

Abstract:

Introduction Thyroid cancer is a malignant disease with poor prognosis. The PI3K/Akt/mTOR and Cyclin-Dependent Kinase 4 (CDK4) pathways are vital regulators of tumor cell proliferation and survival. Therefore the present study was designed to use dual inhibition of such pathways to kill thyroid cancer cells. Methods and materials The effects of each inhibitors on human ATC and BCPAP cell lines were evaluated by MTT assay. The suitable concentrations of inhibitors were determined and synergistic effects of such inhibitors were evaluated by bax/bcl-2 mRNA ratio, Caspase-3, and Caspase-9 activity assay as well as Akt, mTOR, and CDK4. Results:Our finding showed that both ATC and BCPAP cell proliferation is significantly inhibited by PD-332991(PD) and NVP-BEZ235 (NVP) in a time and concentration-dependent manner (P

Authors

Neda Hamidipour

Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran

Mehdi Fazeli

Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran

Mehdi Hedayati

۲. Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mohsen Dehghani

Rayan Pars Pharmacutical Industry, shiraz, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ahmed, H. (2005). Principles and reactions of protein extraction, purification, ...
  • Ansari, A, Gheysarzadeh, A, Mofid, MR. (2017).The interaction of insulin-like ...
  • Ashton, JC. (2015). Drug Combination Studies and Their Synergy Quantification ...
  • Brown, RL, de Souza, JA, Cohen, EE. (2011). Thyroid cancer: ...
  • Brown, KK, Toker, A. (2015). The phosphoinositide 3-kinase pathway and ...
  • del Alcazar, CRG, Hardebeck, MC, Mukherjee, B, Tomimatsu, N, Gao, ...
  • Elkabets, M, Vora, S, Juric, D, Morse, N, Mino-Kenudson, M, ...
  • Gheysarzadeh, A, Yazdanparast, R. (2012).Inhibition of H2O2-induced cell death through ...
  • Gheysarzadeh, A, Ansari, A, Emami, MH, Razavi, AE, Mofid, MR. ...
  • Gheysarzadeh, A, Bakhtiari, H, Ansari, A, EmamiRazavi, A, Emami, MH, ...
  • Gheysarzadeh, A, Sadeghifard, N, Afraidooni, L, Pooyan, F, Mofid, MR, ...
  • Hamzeloo-Moghadam, M, Aghaei, M, Fallahian, F, Jafari, SM, Dolati, M, ...
  • Hedinger, C, Dillwyn Williams, E, Sobin, LH. (1989). The WHO ...
  • Hou, P, Liu, D, Shan, Y, Hu, S, Studeman, K, ...
  • Jafari, E, Gheysarzadeh, A, Mahnam, K, Shahmohammadi, R, Ansari, A, ...
  • Lee, HJ, Lee, WK, Kang, CW, Ku, CR, Cho, YH, ...
  • Lopes-Ventura, S, Pojo, M, Matias, A, Moura,M, Marques, I, Leite, ...
  • Maleki, F, Noorkhoda, S, Halabian, R, Behzadi, E, Fooladi, AAI. ...
  • Maleki, F, Sadeghifard, N, Hosseini, HM, Bakhtiyari, S, Goleij, Z, ...
  • Markman, B, Tabernero, J, Krop, I, Shapiro, G, Siu, L, ...
  • Mazzaferri, EL, Kloos, RT. (2001). Current approaches to primary therapy ...
  • Nix, P, Nicolaides, A, Coatesworth, A. (2005). Thyroid cancer review ...
  • Nozhat, Z, Mohammadi-Yeganeh, S, Azizi, F, Zarkesh, M, Hedayati, M. ...
  • Peyton, J, RodonAhnert, J, Burris, H, Britten, C, Chen, L, ...
  • Pojo, M, Lopes-Ventura, S, Matias, A, Leite, V, Cavaco, B. ...
  • Pópulo, H, Lopes, JM, Soares, P. (2012). The mTORsignalling pathway ...
  • Rahib, L, Smith, BD, Aizenberg, R, Rosenzweig, AB, Fleshman, JM, ...
  • Tagliaferri, L, Gobitti, C, Colloca, GF, Boldrini, L, Farina, E, ...
  • Vasko, V, Saji, M, Hardy, E, Kruhlak, M, Larin, A, ...
  • Vivanco, I, Sawyers, CL. (2002).The phosphatidylinositol 3-kinase–AKT pathway in human ...
  • Wartofsky, L, Van Nostrand, D. (2016). Thyroid cancer: a comprehensive ...
  • Wu, P, Nielsen, TE, Clausen, MH. (2015). FDA-approved small-molecule kinase ...
  • Zarkesh, M, Zadeh-Vakili, A, Akbarzadeh, M, Fanaei, SA, Hedayati, M, ...
  • نمایش کامل مراجع